bioprosthesis


Also found in: Dictionary.

bioprosthesis

 [bi″o-pros-the´sis]
a prosthesis made of biological material.

bioprosthesis

/bio·pros·the·sis/ (-pros-the´sis) a prosthesis that contains biological material.bioprosthet´ic

bioprosthesis

Any implanted device of natural (i.e., nonsynthetic) origin designed to replace a defective body part—e.g., a porcine heart valve.

bioprosthesis

An implanted device of natural–ie, nonsynthetic origin–eg, porcine tissue designed to replace a defective body part–eg, a heart valve. See Heart-valve prosthesis.
References in periodicals archive ?
Special medical supplies for interventional cardiology and cardiac surgery with regard to self-expandable aortic bioprosthesis and balloon expandable aortic bioprosthesis.
Previously published reports of balloon valvuloplasty of a stenotic bioprosthesis in the tricuspid valve position First Mean RA-RV Valve Balloon Outcome author gradient type type (mm Hg) Pre Post Yunoki (1) 13 6 C-E Unknown Unknown Petrou (2) 13 6 C-E Inoue Died 2 months later Reddy (3) 16 12 Mosaic Nucleus-X NYHA Class II 29 mm symptoms at 6 weeks Harle (4) 7 2 Unknown Tyshak II NYHA Class I symptoms at 6 months C-E indicates Carpentier-Edwards; NYHA, New York Heart Association; RA, right atrium; RV, right ventricle.
My goal is to help deliver a pipeline of innovative bioprosthesis systems in a more rapid fashion.
Transthoracic and transesophageal echocardiograms showed a thickened and partial aortic stenosis around the bioprosthesis.
The 40 explanted valves in this series had a relatively long period of bioprosthesis survival (14.
The Toronto Root(TM) bioprosthesis combines the proven advantages of the Toronto SPV(R) valve with the added benefit of St.
2- The ISTHMUS Investigators - The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis - European Journal of Cardio-thoracic Surgery 39 (2011) 18-26
Since our initial experience with the HeartMate II device, we have treated patients with significant AR at the time of HeartMate II implantation by replacing the aortic valve with a bioprosthesis.
Because of progressive stenosis, the patient underwent aortic valve replacement with a bioprosthesis in May 2011.
Since 2003 to July 2008, seventy-eight patients with history of TOF repair or pulmonary valvotomy underwent bioprosthesis PVR.
the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE)Registry, Circulation.